Target intelligence / Profile preview

T-cell receptor specific for Tetanus toxoid peptide-MHC class II complex (Tet-specific TCR)

Target
Tet-specific TCR
Molecular classification
T-cell receptor, Receptor
01

Overview

CD4+ T-cell receptors specific for TET-P–MHC class II complexes are specialized recognition molecules found on the surface of helper T lymphocytes that specifically bind to peptides derived from the Tetanus toxoid (TET-P) when presented by Major Histocompatibility Complex (MHC) class II molecules. These receptors are fundamental to the adaptive immune response, as their engagement triggers the activation of CD4+ T cells, which then produce essential cytokines such as interferon-gamma (IFN-γ) and interleukin-2 (IL-2). In clinical research and vaccine development, Tetanus helper peptides are frequently utilized as universal epitopes to provide the necessary T-cell help for inducing potent immune responses against other antigens, such as those found in cancer or viral infections. Because a large majority of the human population has been previously immunized against Tetanus, these TCRs represent a pre-existing and readily recruitable population of memory cells that can be leveraged to enhance the efficacy of various therapeutic interventions. Monitoring the frequency and activity of T cells bearing these TCRs serves as a vital biomarker for assessing the immunogenicity and success of vaccine-based therapies.

Other names
Tetanus-specific T-cell receptorTetanus toxoid peptide-specific TCRCD4+ T-cell receptor (Tetanus)Tet-P-specific TCRTetanus helper peptide-specific TCR
02

Mechanism of action

Activation of CD4+ T cells via TCR-CD3 complex signaling upon recognition of the TET-P–MHC II complex, leading to the secretion of cytokines (IFN-gamma, IL-2) and expression of CD40L, which supports CD8+ T cell and B cell responses.

03

Biological functions

Immune responseT-cell activationCytokine productionHelper T-cell functionDendritic cell licensing
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

MHC restriction (HLA-dependency)Potential for excessive inflammatory responsePre-existing immunity variability among patients
06

Interacting drugs

Tetanus toxoid

3 more in the full profile.

07

Biomarkers

IFN-gamma ELISpotMHC-peptide tetramer stainingCD154 (CD40L) expressionIntracellular cytokine staining (ICS)

Beyond the preview

Go deeper on T-cell receptor specific for Tetanus toxoid peptide-MHC class II complex (Tet-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor specific for Tetanus toxoid peptide-MHC class II complex (Tet-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call